Mission
At CRISPR Therapeutics, we are focused on developing transformative gene-based medicines for serious human diseases
We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-editing platform into therapies to treat hemoglobinopathies, cancer, diabetes and other diseases
Our multi-disciplinary team of world-class researchers and drug developers works every day to translate our CRISPR/Cas9 technology into breakthrough human therapeutics. We are advancing a variety of programs across our four core franchises: hemoglobinopathies, immuno-oncology, regenerative medicine, and in vivo.
Building a great company with a focus on science, innovation, collaboration and entrepreneurship
Our revolutionary technology provides the foundation for building a sustainable innovation engine and a place to foster entrepreneurship across all fronts. We’re always looking for talented, experienced and passionate individuals to join us. We have our headquarters in Zug, Switzerland, our R&D operations in Boston, Massachusetts, USA, manufacturing operations in Framingham, Massachusetts, USA, and additional business operations in San Francisco, California. Please visit the careers page for more information.
